MedTrace Logo

Helicobacter Pylori Empiric Treatment in Ulcer Bleeding

NCT00687336 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2009-07-08

No results posted yet for this study

Summary

The goal of the study is to compare the effectiveness of empirical Helicobacter pylori treatment compared with treatment depending on diagnostic tests for Helicobacter pylori in patients with Upper gastrointestinal bleeding due to peptic ulcer. Main hypothesis is that empirical treatment will reduce the number of patients lost to follow-up thus improving the cure rates of Hp infection.

Conditions

  • Peptic Ulcer Hemorrhage

Interventions

OTHER

Empirical Hp eradication

Empirical Helicobacter pylori treatment initiated immediately after oral intake is resumed

OTHER

Eradication treatment guided by a positive test

Eradication treatment given if there is at least one positive diagnostic test (URT, histological test, breath test or serology) for Helicobacter pylori.

Sponsors & Collaborators

  • Corporacion Parc Tauli

    collaborator OTHER

  • Consorcio Centro de Investigación Biomédica en Red (CIBER)

    collaborator OTHER_GOV

  • Hospital de Sabadell

    lead OTHER

Principal Investigators

  • Pilar Garcia, Dra. · Hospital de Sabadell

  • Xavier Calvet, Dr. · Hospital de Sabadell

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00687336 on ClinicalTrials.gov